{"address1": "322 11th Avenue SW", "address2": "Suite 804", "city": "Calgary", "state": "AB", "zip": "T2R 0C5", "country": "Canada", "phone": "403 670 7377", "website": "https://www.oncolyticsbiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oncolytics Biotech Inc. operates as a clinical-stage biopharmaceutical company. The company develops pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms to improve the ability of the immune system to fight cancer, making tumors more susceptible to a range of oncology treatments. It entered an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. The company was incorporated in 1998 and is headquartered in Calgary, Canada.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Mr. Wayne F. Pisano M.B.A.", "age": 69, "title": "Interim CEO & Chairman of the Board", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 216752, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kirk J. Look C.A., CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "totalPay": 469090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas C. Heineman M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "totalPay": 558908, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison  Hagerman P.Eng., P.M.P.", "title": "Vice President of Product Development", "fiscalYear": 2024, "totalPay": 339805, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy Goodowitz Levin B.S.N., R.N.", "title": "Vice President of Clinical Operations", "fiscalYear": 2024, "totalPay": 375452, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jon  Patton", "title": "Director of Investor Relations & Communication", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christophe  Degois", "title": "Vice President of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.", "title": "Consultant", "fiscalYear": 2024, "totalPay": 18049, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.55, "open": 0.5432, "dayLow": 0.527, "dayHigh": 0.55, "regularMarketPreviousClose": 0.55, "regularMarketOpen": 0.5432, "regularMarketDayLow": 0.527, "regularMarketDayHigh": 0.55, "payoutRatio": 0.0, "beta": 1.489, "forwardPE": -1.7566667, "volume": 240735, "regularMarketVolume": 240735, "averageVolume": 1081593, "averageVolume10days": 156690, "averageDailyVolume10Day": 156690, "bid": 0.5208, "ask": 0.5416, "bidSize": 10, "askSize": 5, "marketCap": 46237244, "fiftyTwoWeekLow": 0.527, "fiftyTwoWeekHigh": 1.53, "fiftyDayAverage": 0.6972, "twoHundredDayAverage": 0.92525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 30666178, "profitMargins": 0.0, "floatShares": 82982877, "sharesOutstanding": 86421600, "sharesShort": 3000206, "sharesShortPriorMonth": 3052143, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0347, "heldPercentInsiders": 0.04355, "heldPercentInstitutions": 0.01615, "shortRatio": 9.7, "shortPercentOfFloat": 0.0361, "impliedSharesOutstanding": 87736704, "bookValue": 0.075, "priceToBook": 7.0266666, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -31710000, "trailingEps": -0.29, "forwardEps": -0.3, "lastSplitFactor": "10:95", "lastSplitDate": 1527206400, "enterpriseToEbitda": -0.879, "52WeekChange": -0.5181818, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.527, "targetHighPrice": 5.021148, "targetLowPrice": 3.01241, "targetMeanPrice": 4.0167794, "targetMedianPrice": 4.0167794, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 15942000, "totalCashPerShare": 0.184, "ebitda": -34880000, "totalDebt": 1064000, "quickRatio": 2.394, "currentRatio": 2.823, "debtToEquity": 17.784, "returnOnAssets": -0.74106, "returnOnEquity": -1.89054, "freeCashflow": -16339750, "operatingCashflow": -26966000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "ONCY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_1340759", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743595205, "regularMarketTime": 1743537600, "regularMarketChangePercent": -4.1818185, "regularMarketPrice": 0.527, "shortName": "Oncolytics Biotech Inc.", "longName": "Oncolytics Biotech Inc.", "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1002288600000, "preMarketChange": 0.023000002, "preMarketChangePercent": 4.3643265, "preMarketPrice": 0.55, "regularMarketChange": -0.023000002, "regularMarketDayRange": "0.527 - 0.55", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1081593, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.527 - 1.53", "fiftyTwoWeekHighChange": -1.003, "fiftyTwoWeekHighChangePercent": -0.6555556, "fiftyTwoWeekChangePercent": -51.81818, "dividendDate": 1527206400, "earningsTimestamp": 1741348807, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1741354200, "earningsCallTimestampEnd": 1741354200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.29, "epsForward": -0.3, "epsCurrentYear": -0.39833, "priceEpsCurrentYear": -1.3230237, "fiftyDayAverageChange": -0.17019999, "fiftyDayAverageChangePercent": -0.24411932, "twoHundredDayAverageChange": -0.39824998, "twoHundredDayAverageChangePercent": -0.43042418, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Oncolytics Biotech", "trailingPegRatio": null}